Übersetzung für "Wirkstoffkandidaten" in Englisch

The clinical trials of potential active substances are divided into different phases.

The new potential drugs are then put through suitable test systems in order to analyze tolerance and dose-finding.

The search for new drug candidates for cancer treatment is laborious and time-consuming.

Promising drug candidates are further developed, improved and tested for possible side effects.

Several drug candidates were discovered within the context of the project APN411.

The development of the drug candidate at Forschungszentrum Jülich has so far been funded from the Helmholtz Validation Fund.

The Roche experts select only the most promising drug candidates for further investigation in clinical studies.

Merck Serono will be responsible for drug development and commercialization for selected drug candidates.

Our focus now is on completing clinical trials for two promising new antimalarial drug candidates.

Isis has numerous drug candidates in Phase III development in severe/rare diseases and cardiovascular diseases.

In silico, computational, model-based simulations help us to identify promising drug candidates faster and with more precision.

Researchers at Jülich have therefore developed a novel drug candidate that selectively targets the most harmful aggregate species.

With over 30 drug candidates, the US biotech firm has one of the broadest development pipelines in the biotech industry.

The end of a partnership: MorphoSys has withdrawn the rights to the drug candidate MOR202 from US biotech giant Celgene.

Giese and Griesinger have successfully continued their cooperation with the development of further chemically modified drug candidates.

The corresponding active ingredient candidates are currently being prepared and will be investigated in collaboration with a company specializing in this area.

Under the terms of the agreement, LDC will receive research funding, and for selected drug candidates, milestone and royalty payments.

The DZD, for example, has developed a novel drug candidate for the treatment of type 2 diabetes*.

In its Proprietary Development segment, MorphoSys focuses on the research and clinical development of its own drug candidates.

It won’t be easy to manage a large pool of candidate compounds and dozens of simultaneous drug trials.

Thanks very promising study results from pharmaceutical companies in recent months, a genuine run has begun on corresponding drug candidates from the labs of biotech firms, with the aim of building up pipelines.

We help you make crucial decisions to efficiently advance the right drug candidate into your preclinical and clinical phases.

BioSpring is thus able to provide you with small scale oligonucleotides, which have proven to be potential API candidates in your research, in the quality you have come to expect all the way through until they are used as APIs in potential pharmaceutical end products.

Roche is at the very forefront of cancer immunotherapy, with ten investigational candidates currently in the clinical development phase.

In the first phase of GO-Bio Ulrich Bogdahn’s team plans to preclinically develop possible active substances for the commencement of clinical studies.

Over the current financial year, Pharnext is continuing its Phase 3 clinical trial for its drug candidate PXT3003 in CMT1A.

In Q2 2019 MorphoSys continued to focus on the research and development of drug candidates both for its own account as well as with its partners.